RJ, O., L, M., M, S., N, Y., P, H., LV, G., . . . B, F. (2026). Tailored FcγR blockade enhances immune checkpoint therapy and overcomes resistance. Journal of experimental & clinical cancer research : CR, 45(1), . https://doi.org/10.1186/s13046-026-03785-5
Chicago Style (17th ed.) CitationRJ, Oldham, et al. "Tailored FcγR Blockade Enhances Immune Checkpoint Therapy and Overcomes Resistance." Journal of Experimental & Clinical Cancer Research : CR 45, no. 1 (2026). https://doi.org/10.1186/s13046-026-03785-5.
MLA (9th ed.) CitationRJ, Oldham, et al. "Tailored FcγR Blockade Enhances Immune Checkpoint Therapy and Overcomes Resistance." Journal of Experimental & Clinical Cancer Research : CR, vol. 45, no. 1, 2026, https://doi.org/10.1186/s13046-026-03785-5.